BioLight Life Sciences Ltd. (TLV:BOLT)
300.00
+1.00 (0.33%)
Nov 12, 2026, 5:24 PM IST
BioLight Life Sciences Market Cap
BioLight Life Sciences has a market cap or net worth of 27.24 million as of November 12, 2026. It is the 42,242nd most valuable company in the world and the 444th biggest in Israel. Its market cap has decreased by 25.32% in one year.
Market Cap
27.24M
Enterprise Value
15.22M
Revenue
n/a
Global Rank
Country Rank
#444 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since January 11, 2006, BioLight Life Sciences's market cap has decreased from 47.74M to 27.24M, a decrease of -42.95%. That is a compound annual growth rate of -2.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 26.14M | -17.88% |
| Dec 31, 2025 | 31.83M | 25.69% |
| Dec 31, 2024 | 25.32M | 4.99% |
| Dec 31, 2023 | 24.12M | -19.99% |
| Dec 29, 2022 | 30.15M | -42.70% |
| Dec 30, 2021 | 52.62M | 53.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 184.57M |
| Matricelf | 79.42M |
| Clal Biotechnology Industries | 33.09M |
| Purple Biotech | 32.42M |
| BioLineRx | 29.87M |
| Evogene | 18.35M |
| XTL Biopharmaceuticals | 17.22M |
| Can-Fite BioPharma | 15.16M |